PYC 8.33% 11.0¢ pyc therapeutics limited

PYC, page-39

  1. SoT
    849 Posts.
    lightbulb Created with Sketch. 103
    I recorded the audio and Rohan said they've filed for IP protection for two CNS candidates. He said they have a focus on autophagy production (a pathway in neurogenerative diseases) and neuroinflammation. He referred to the gazumped target as progranulin. Deficiency of progranulin in the CNS causes neurodegeneration and neuroinflammation.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.